A potentially effective drug for patients with recurrent glioma: sermorelin

BACKGROUND: Treatment insensitivity is the main cause of glioma. This study was designed to screen out effective drugs for recurrent gliomas based on the transcriptomics data. METHODS: A total of 1,018 glioma patients with transcriptome sequencing data and clinical data were included in this study....

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Yuanhao, Huang, Ruoyu, Zhai, You, Huang, Lijie, Feng, Yuemei, Wang, Di, Chai, Ruichao, Zhang, Wei, Hu, Huimin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8033379/
https://www.ncbi.nlm.nih.gov/pubmed/33842627
http://dx.doi.org/10.21037/atm-20-6561

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8033379/
https://www.ncbi.nlm.nih.gov/pubmed/33842627
http://dx.doi.org/10.21037/atm-20-6561

Ejemplares similares